Related Experiment Video
Updated: Jun 6, 2026

Expanding the Toolkit for In Vivo Imaging of Axonal Transport
Published on: December 23, 2021
Deficits in axonal transport precede ALS symptoms in vivo
Lynsey G Bilsland1, Erik Sahai, Gavin Kelly
1Molecular NeuroPathobiology Laboratory, Cancer Research UK London Research Institute, London WC2A 3LY, United Kingdom.
Abstract:
ALS is a fatal neurodegenerative disease characterized by selective motor neuron death resulting in muscle paralysis. Mutations in superoxide dismutase 1 (SOD1) are responsible for a subset of familial cases of ALS. Although evidence from transgenic mice expressing human mutant SOD1(G93A) suggests that axonal transport defects may contribute to ALS pathogenesis, our understanding of how these relate to disease progression remains unclear. Using an in vivo assay that allows the characterization of axonal transport in single axons in the intact sciatic nerve, we have identified clear axonal transport deficits in presymptomatic mutant mice. An impairment of axonal retrograde transport may therefore represent one of the earliest axonal pathologies in SOD1(G93A) mice, which worsens at an early symptomatic stage. A deficit in axonal transport may therefore be a key pathogenic event in ALS and an early disease indicator of motor neuron degeneration.
Insights
Axonal transport deficits, particularly retrograde transport, are early indicators of motor neuron degeneration in familial Amyotrophic Lateral Sclerosis (ALS) caused by SOD1 mutations. These impairments worsen as the disease progresses.
Area of Science:
- Neuroscience
- Neurodegenerative Diseases
- Motor Neuron Disorders
Background:
- Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease causing motor neuron death and paralysis.
- Mutations in superoxide dismutase 1 (SOD1) are linked to familial ALS cases.
- Axonal transport defects are suspected contributors to ALS pathogenesis, but their role in disease progression is not fully understood.
Purpose of the Study:
- To investigate the role and timing of axonal transport deficits in the pathogenesis of ALS.
- To characterize axonal transport in presymptomatic and symptomatic stages of SOD1 mutant mouse models.
Main Methods:
- Utilized an in vivo assay to analyze axonal transport in single axons within the intact sciatic nerve.
- Examined axonal transport in presymptomatic and early symptomatic stages of mice expressing human mutant SOD1(G93A).
Main Results:
- Identified significant axonal transport deficits in presymptomatic SOD1(G93A) mutant mice.
- Observed an impairment of axonal retrograde transport as an early pathological event.
- Demonstrated that these transport deficits worsen during the early symptomatic stage of the disease.
Conclusions:
- Impaired axonal retrograde transport is a key early pathogenic event in SOD1-linked ALS.
- Axonal transport deficits serve as an early indicator of motor neuron degeneration in ALS.
- Understanding these early defects may offer therapeutic targets for slowing ALS progression.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Neurons: The Axon
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment.
